Important pharmacy news and late-breaking industry information updated daily.

FDA said Wednesday that it will temporarily allow certain manufacturers to sell losartan containing N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the interim acceptable intake limit of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.

FDA approved on Tuesday brexanolone (Zulresso—Sage Therapeutics) injection for I.V. use for the treatment of postpartum depression (PPD) in adults women.

Taking a low-dose (75–100 mg) aspirin daily is no longer recommended for heart disease and stroke prevention among healthy older adults, according to the 2019 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Primary Prevention of Cardiovascular Disease, published on March 17.

New data on trends in opioid prescribing across the United States show that the amount of opioids prescribed decreased, but long-term prescriptions for opioids increased.

A new report from CDC highlights the need to expand HIV testing and treatment in the United States. The report also noted the importance of helping people with HIV take medicine and maintain viral suppression.

The American College of Cardiology (ACC) and American Heart Association on Sunday said low-dose aspirin should not be given on a routine basis for the purpose of preventing heart attacks and other heart disease in people aged 70 years and older or adults of any age who are at increased risk of bleeding.

Tramadol prescriptions among patients with osteoarthritis have been increasing since 2000. But a new study published March 12 in JAMA calls into question how safe tramadol really is for patients with osteoarthritis, whose main treatment goal is to control pain while avoiding therapeutic toxicity. Tramadol is thought to be a better alternative to NSAIDs and traditional opioids mostly because it has a lower risk of serious cardiovascular and gastrointestinal adverse effects.

CMS reports that it updated its Drug Spending Dashboards with data for 2017. The dashboards, first released in May 2018, add information on the manufacturers that are responsible for prices hikes and include pricing and spending data for thousands of drugs across Medicare Parts B and D and Medicaid.

When the popular blood pressure medication valsartan was pulled from pharmacy shelves late last summer, pharmacy staff at Dilworth Drug & Wellness Center in North Carolina reached out to patients taking the medication and notified them of the recall before it became national news.

FDA on Wednesday proposed to end current compliance policy as it applies to flavored electronic nicotine delivery system (ENDS) products such as electronic cigarettes, and prioritize enforcement of such products offered for sale in ways that pose a greater risk for minors to access these tobacco products.